Annual Veterinary Cancer Society Conference 2011:
Development and Characterization of Canine Lymphoma Cell Lines derived from Clinical Lymphoma Cases
Unlocking the Potential of Cancer Vaccines: Harnassing the Power of the Immune System to Fight Cancer Conference 2010:
ImmuneFx™ autologous cancer vaccine breaks immuno-protection of refractory cancers in murine model and companion animals with naturally occurring disease by evoking strong humoral and cellular immune responses, supporting expectations of efficacy in human trials
Annual Veterinary Cancer Society Conference 2009:
RNA interference (RNAi): An experimental molecular therapeutic approach to the treatment of cancers of the cerebellum
Annual Veterinary Cancer Society Conference 2009:
Therapeutic canine lymphoma vaccine produces anti-cancer response in dogs treated with chemotherapy
Theilen Tribute Symposium 2008:
Anti-tumor response induced by autologous cancer vaccine in canine lymphoma
Annual Veterinary Cancer Society Conference 2007:
Anti-Tumor Response Induced By Autologous Cancer Vaccine In Canine Lymphoma: A Case Study
American Association for Cancer Research Annual Meeting 2007:
A Novel Cancer Vaccine Meets Canine Trial Endpoints
WilBio's 12th Annual Cell & Tissue BioProcessing Conference 2007:
Comprehensive Cancer Management from a Cellular Bioprocessing Perspective
American Association for Cancer Research Annual Meeting 2005
A non-Invasive Immune Therapy For Cancers Resistant To Conventional Treatments
International Society for Biological Therapy of Cancer 2005:
ImmuneFx™: A Novel Immunotherapeutic Cancer Vaccine
Abstracts
Change is the way of life
Abstracts
4613 N Clark Avenue, Tampa, FL 33614
